search icon

    Market Snapshot

    blog search icon

    Onconova Therapeutics, Inc. (NASDAQ: ONTX), stock rising above the skies in the pre-market

    By Hasnain R

    Dec 01,2020

    4:41 AM UTC

    Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biotechnology corporation dedicated to the research and production of innovative cancer therapy drugs surged over 31% at $0.38 in pre-market trading Tuesday, on no news.

    However, recently the company announced the registration with the U.S. of an Investigational New Drug (IND) application Food and Drug Administration (FDA) for the patented, differentiated, first-in-class multi-kinase inhibitor of the Business, ON 123300. The IND is seeking permission to launch a Phase 1 trial with ON 123300 in patients with HR+ HER 2-metastatic breast cancer with resistance to licenced second-generation CDK4/6 inhibitors for relapsed/refractory advanced cancer.

    More From Stocks telegraph